Three large-scale association studies provide insights into the genetic architecture of blood pressure regulation, identifying new common variants of modest effect and providing insights into the impact of rare and low-frequency variants. The findings suggest that newly identified variants act through indirect disease pathways and suggest targeting of causal networks might improve outcomes in patients with hypertension.
- Nicholette D. Palmer
- Barry I. Freedman
